Sunday, 3 March 2024

Business News

Catalent price target raised to $63.50 from $56 at Baird – TipRanks Financial Blog

LianBio reports Q3 EPS (20c), consensus (39c)

Baird raised the firm’s price target on Catalent to $63.50 from $56 and keeps an Outperform rating on the shares. The firm said Q2 showed a revenue beat, while adjusted EBITDA and EPS missed and noting that overall PCH was solid, but Biologics disappointed, with some kitchen sinking of costs driving lower results in front of buyout.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on CTLT:

Click Here to Read the Full Original Article at TipRanks Financial Blog…